Profiles of microRNAs in Patients with Advanced Breast Cancer Who are Chemoresistant or Chemosensitive to Fluorouracil, Adriamycin, and Cyclophosphamide Treatment

Volume 27, Issue 2, February 2026, Pages 469-479

Eneida Turiján-Espinoza; Victor Manuel Ruíz-Rodríguez; Victor Alejandro Paz-Rodríguez; Gloria Estela Hernández-Hernández; Osiel Hernández-González; Jaime Arturo Guel-Pañola; José de Jesús Zermeño-Nava; Mary Carmen Gutiérrez-Gil; Diana Patricia Portales-Pérez

• View Article
• PDF 951.56 K

Expression of Survivin and HER-2 as Independent Predictive Factors for Treatment Response in Locally Advanced Breast Cancer: A Prospective Cohort Study

Volume 27, Issue 2, February 2026, Pages 569-573

San Winata Badiri; Indra Indra; Elridho Sampepajung; John Pieter Jr; Berti J. Nelwan; Djonny Ferianto; Salman Ardi Syamsu; Muhammad Faruk

• View Article
• PDF 279.66 K

Markers of Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: New in Molecular Oncology

Volume 25, Issue 11, November 2024, Pages 3761-3769

Ekaterina Kravtsova; Matvey Tsyganov; Irina Tsydenova; Daria Dolgasheva; Ksenia Gaptulbarova; Nikolai Litviakov; Marina Ibragimova

• View Article
• PDF 1.26 M

Evaluating the Outcome and Patient Safety of Methotrexate, Doxorubicin, and Cisplatin Regimen for Chemotherapy in Osteosarcoma: A Meta-Analysis

Volume 25, Issue 5, May 2024, Pages 1497-1505

Mohamad Dimas Ismail; I Gede Eka Wiratnaya; Risang Haryo Raditya

• View Article
• PDF 1.13 M

Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer

Volume 23, Issue 11, November 2022, Pages 3641-3647

Anupong Sawasdee; Monthira Tanthanuch; Tanan Bejrananda

• View Article
• PDF 549.03 K

Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer

Volume 21, Issue 6, June 2020, Pages 1717-1723

Amr Sakr; Mamdouh Elsherbiny; Rabab Abdel Moneim; Saeed Shaaban; Moustafa Aldaly

• View Article
• PDF 335.27 K

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: Correlation between Androgen Receptor Expression and Pathological Response

Volume 21, Issue 2, February 2020, Pages 563-568

Amrallah A Mohammed; Fifi Mostafa Elsayed; Mohammed Algazar; Hayam E Rashed; Abeer Hussien Anter

• View Article
• PDF 476.19 K

Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer

Volume 21, Issue 1, January 2020, Pages 93-98

Narendra Hulikal; Sivanath Reddy Gajjala; Teckchand Kalawat; Silpa Kadiyala; Radhika Kottu

• View Article
• PDF 355.23 K

Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients

Volume 20, Issue 9, September 2019, Pages 2749-2755

Neemat M Kassem; Wael S Makar; Hebatallah A Kassem; Soha Talima; Mustafa Tarek; Hadeer Hesham; Mohamed A El-Desouky

• View Article
• PDF 368.88 K

The Neutrophil to Lymphocyte Ratio Predicts the Response to Neoadjuvant Chemotherapy in Luminal B Breast Cancer

Volume 20, Issue 7, July 2019, Pages 2209-2212

Mauricio Rivas; Francisco Acevedo; Francisco Dominguez; Hector Galindo; Mauricio Camus; David Oddo; Alejandra Villarroel; Dravna Razmilic; Jose Peña; Matias Munoz Medel; Maria Elena Navarro; Alejandra Perez-Sepulveda; Lidia Medina; Tomas Merino; Juan Briones; Alexis Kalergis; Cesar Sanchez

• View Article
• PDF 318.75 K

Outcome of Combined Neoadjuvant Chemotherapy and Vitamin A in Advanced Cervical Carcinoma: A Randomized Double-Blind Clinical Trial

Volume 20, Issue 7, July 2019, Pages 2213-2218

Rizal Sanif Sanusi

• View Article
• PDF 267.93 K

The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-κb), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients

Volume 20, Issue 5, May 2019, Pages 1511-1518

Yan Wisnu Prajoko; Teguh Aryandono

• View Article
• PDF 758.39 K

Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients

Volume 19, Issue 9, September 2018, Pages 2423-2427

Pegah Sasanpour; Saleh Sandoughdaran; Alireza Mosavi-Jarrahi; Mona Malekzadeh

• View Article
• PDF 260.15 K

Insulin-Like Growth Factors and Their Binding Proteins in Tumors and Ascites of Ovarian Cancer Patients: Association With Response To Neoadjuvant Chemotherapy

Volume 17, Issue 12, December 2016, Pages 5315-5320

Natalia V. Yunusova; Alisa B. Villert; Liudmila V. Spirina; Alena E. Frolova; Larisa A. Kolomiets; Irina V. Kondakova

• View Article
• PDF 269.44 K

Response of Triple Negative Breast Cancer to Neoadjuvant Chemotherapy: Correlation between Ki-67 Expression and Pathological Response

Volume 17, Issue 2, February 2016, Pages 807-813

• View Article
• PDF 779.61 K

Predictive Value of IHC4 Score for Pathological Response to Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer

Volume 16, Issue 17, December 2015, Pages 7975-7979

• View Article
• PDF 391.65 K

Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer

Volume 16, Issue 11, November 2015, Pages 4603-4608

• View Article
• PDF 709.25 K

Role of Neoadjuvant Chemotherapy in the Management of Advanced Ovarian Cancer

Volume 16, Issue 6, June 2015, Pages 2369-2373

• View Article
• PDF 517.38 K

The Neutrophil to Lymphocyte Ratio has a High Negative Predictive Value for Pathologic Complete Response in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Volume 15, Issue 18, December 2014, Pages 7737-7740

• View Article
• PDF 330.96 K

Molecular Types and Neoadjuvant Chemotherapy in Patients with Breast Cancer- While Molecular Shifting is More Common in Luminal a Tumors, The Pathologic Complete Response is Most Frequently Observed in Her-2 Like Tumors

Volume 15, Issue 21, December 2014, Pages 9379-9383

• View Article
• PDF 611.62 K

Locally Advanced Breast Cancer in Jamaica: Prevalence, Disease Characteristics and Response to Preoperative Therapy

Volume 15, Issue 7, July 2014, Pages 3323-3326

• View Article
• PDF 292.95 K

Expression of Nuclear Factor Kappa B (NF-κB) as a Predictor of Poor Pathologic Response to Chemotherapy in Patients with Locally Advanced Breast Cancer

Volume 15, Issue 2, February 2014, Pages 595-598

• View Article
• PDF 335.94 K

Reduction of Proliferation and Induction of Apoptosis are Associated with Shrinkage of Head and Neck Squamous Cell Carcinoma due to Neoadjuvant Chemotherapy

Volume 14, Issue 11, November 2013, Pages 6419-6425

• View Article
• PDF 10.24 M

Comparison of Clinical Efficacy of Three Different NeoadjuvantApproaches (Chemotherapy Combined Vaginal Intracavitary Irradiation, Neoadjuvant Chemotherapy Alone or Radiotherapy) Combined with Surgery for Patients with Stage Ib2 and IIa2 Cervical Canc

Volume 14, Issue 4, April 2013, Pages 2377-2381

• View Article
• PDF 392.55 K

Predictive Factors Determining Neoadjuvant Chemotherapy Outcomes in Breast Cancer - a Single Center Experience

Volume 14, Issue 4, April 2013, Pages 2401-2406

• View Article
• PDF 385.62 K